EUCTR2007-006785-15-ES进行中（未招募）不适用
EFFICACY AND SECURITY OF INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANES ASSOCIATED TO HIGH MYOPIA EVALUACIÓN DE LA EFICACIA Y SEGURIDAD DE LA INYECCIÓN INTRAVÍTREA DE BEVACIZUMAB EN LA NEOVASCULARIZACIÓN COROIDEA ASOCIADA A LA MIOPÍA MAGNA
IOBA - Instituto Universitario de Oftalmobiología Aplicada0 个研究点开始时间: 2008年1月11日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Signed informed consent
- •2. Signed data protection consent
- •3. Negative pregnancy test in fertile women at baseline.
- •4. Age 18+
- •5. High myopia
- •6. Active choroidal neovascularization (subfoveolar/yuxtafoveolar)
- •7. Visual acuity loss of less than 6 months of evolution
- •8. No atrophic or fibrotic component that may prevent visual acuity improvement.
- •9. Fertile women must commit to use a reliable contraceptive method during the trial.
- •10. Photodinamic Therapy allowed
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Previous vitrectomy in Study Eye
- •2. Tractional maculopathy and/or epiretinal membrane assessed by OCT
- •3. Any media opacities that may prevent the adequate assessment of eye fundus.
- •4. Pseudoaphakia or non integrity of lens´ posterior capsule
- •5. Patient with great possibilities of not being able to complete the study, based in PIs judgement.
研究者
相似试验
进行中（未招募）
不适用
INTRAVITREAL BEVACIZUMAB INJECTION VS. CONVENTIONAL LASER SURGERY FOR VISION-THREATENING RETINOPATHY OF PREMATURITY. - NDEUCTR2009-012609-20-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
已完成
不适用
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational studyretinal diseases or conditions that can be treated with bevacizumab or ranibizumab such as neovascular age-related macular degeneration (neovascular AMD),diabetic macular edema (DME),and macular edeneovascular age-related macular degeneration (neovascular AMD)diabetic macular edema (DME)retinal vein occlusion(RVO)TCTR20141002001Health Intervention and Technology Assessment Program (HITAP)6,399
已完成
不适用
Safety assessment of treatment with bevacizumab in metastatic colorectal cancerMetastatic colorectal cancerMalignant neoplasm of rectosigmoid junctionCancerISRCTN36011949Institute of Oncology Ljubljana (Slovenia)250
招募中
不适用
Efficacy and Safety of Intraperitoneal Bupivacaine Alone or with Dexmedetomidine on Postoperative Analgesia after Laparoscopic CholecystectomySurgeryPostoperative painPACTR201708002497386Ahmed Mohamed Ibrahim Ahmed120
已完成
不适用
Evaluation of Intravitreal injection of Bevacizumab for treatment of Chronic Central Serous Chorioretinopathychronic central serous chorioretinopathy.Disease of the eye and adnexaIRCT201202198983N1Guilan Universoty of Medical Sciences, Pro-vice-chancellor for resea15